SEATTLE, Sept. 10, 2021 (GLOBE NEWSWIRE) -- According to Coherent Market Insights, the global hormonal contraceptives market is estimated to be valued at US$ 15,232.2 Million in 2021 and is expected to exhibit a CAGR of 2.9% over the forecast period (2021-2028).
Key Trends and Analysis of the Global Hormonal Contraceptives Market:
New product launches as well as product expansions is expected to propel the growth of the global hormonal contraceptives market over the forecast period. For instance, in September 2020, Merck Canada Inc., a subsidiary of Merck & Co., Inc., announced that NEXPLANON (etonogestrel implant) 68 mg, a hormonal contraceptive implant, has been launched in Canada.
Furthermore, key players operating in the global hormonal contraceptives market are focusing on adoption of inorganic growth strategies such as acquisition, collaboration, and partnerships to increase their market presence in the global market.
For instance, in February 2020, TherapeuticsMD, Inc., a women’s healthcare company, and Afaxys Pharma, LLC, a pharmaceutical company focused on serving women in the public health system, signed an agreement to increase access to ANNOVERA (segesterone acetate and ethyl estradiol vaginal system) in the U.S. public health sector.
Request for Sample copy of this Report @ https://www.coherentmarketinsights.com/insight/request-sample/4615
Key Market Takeaways:
The global hormonal contraceptives market is expected to exhibit a CAGR of 2.9% during the forecast period, owing to the increasing focus on family planning among the populace. For instance, according to Physical Review B’s (PRB) 2019 Family Planning Data Sheet, globally, 62% of married women aged 15 to 49 use a traditional method of family planning and 56% use a modern method of family planning.
Among hormone, combined hormone contraceptives segment is expected to dominate the market in the forecast period owing to the high availability of combined hormonal contraceptive along with better efficiency to prevent pregnancy.
Competitive Landscape:
Key players operating in the global hormonal contraceptives market include The Female Health Company, Teva Pharmaceutical Industries Limited, Bayer AG, Pfizer, Inc., Mylan N.V., Johnson & Johnson, Ansell Ltd., Mayer Laboratories, Merck & Co., Inc., Church & Dwight, Co., Inc., Afaxys, Inc., Allergan plc., Agile Therapeutics, Apothecus Pharmaceutical Corporation., Novartis AG, Sun Pharmaceutical Industries Ltd., and Cipla Limited.
Buy-Now this Research Report @ https://www.coherentmarketinsights.com/insight/buy-now/4615
Market Segmentation:
- Global Hormonal Contraceptives Market, By Product:
-
- Oral Contraceptive Pills
- Injectable Birth Control
- Emergency Contraceptive Pills
- Vaginal Ring
- Transdermal Patches
- Global Hormonal Contraceptives Market, By Hormone:
-
- Progestin Only Contraceptive
- Combined Hormonal Contraceptive
- Global Hormonal Contraceptives Market, By Age Group:
-
- 15–24 Years
- 25–34 Years
- 35–44 Years
- Above 44 Years
- Global Hormonal Contraceptives Market, By End User:
- Hospitals
- Homecare
- Gynecology Centers
- Clinics
- Ambulatory Surgical Centers
- Global Hormonal Contraceptives Market, By Region:
- North America
- By Country
- U.S.
- Canada
- By Country
- Latin America
- By Country
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- By Country
- Europe
- By Country
- Germany
- U.K.
- France
- Italy
- Spain
- Russia
- Rest of Europe
- By Country
- North America
-
- Asia Pacific
-
-
- By Country
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- By Country
-
-
- Middle East
-
-
- By Country
- GCC
- Israel
- Rest of Middle East
- By Country
-
-
- Africa
-
-
- By Region/Country
- South Africa
- Central Africa
- North Africa
- By Region/Country
-
Related Market Intelligence Reports:
Contraceptives Market, By Type (Drugs (Oral Contraceptive Pills, Injectables, Topical), Devices (Male Condoms, Female Condoms, Diaphragms, Sponges, Vaginal Rings, Subdermal Implants, IUD)), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East & Africa) - Size, Share, Outlook, and Opportunity Analysis, 2020 - 2027
U.S. Contraceptives Drugs And Devices Market, By Product Type (Contraceptive Drugs, Contraceptive Devices (Male Contraceptive Devices, Female Contraceptive Devices)) - Insights, Opportunity Analysis, and Industry Forecast till 2024
About Us:
Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having sales office at global financial capital in the U.S. and sales consultants in United Kingdom and Japan. Our client base includes players from across various business verticals in over 57 countries worldwide.
